BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2066177)

  • 1. Cellular immune recognition of HLA-G-expressing choriocarcinoma cell line Jeg-3.
    Burt D; Johnston D; Rinke de Wit T; Van den Elsen P; Stern PL
    Int J Cancer Suppl; 1991; 6():117-22. PubMed ID: 2066177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MHC class I expression in developmental tumours.
    Stern PL; Rinke de Wit TF
    Semin Cancer Biol; 1991 Feb; 2(1):11-6. PubMed ID: 1912513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin associates with non-HLA-A,-B class I proteins in the human choriocarcinoma cell lines JEG-3 and BeWo.
    Wainwright SD; Simpson KL; Holmes CH
    Immunology; 1998 Mar; 93(3):437-45. PubMed ID: 9640257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells.
    Zdravkovic M; Aboagye-Mathiesen G; Guimond MJ; Hager H; Ebbesen P; Lala PK
    Placenta; 1999; 20(5-6):431-40. PubMed ID: 10419808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of immunoregulatory activity of a choriocarcinoma-derived factor: specific suppression of proliferative process of cell-mediated immune responses including LAK cell generation.
    Matsuzaki N; Saji F; Okada T; Sawai K; Kameda T; Tanizawa O
    J Reprod Immunol; 1991 Feb; 19(2):101-14. PubMed ID: 2008000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choriocarcinoma cell line resistance to NK lysis mainly involves an HLA-G-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Bardos P; Thibault G
    Transplant Proc; 1999 Jun; 31(4):1866-7. PubMed ID: 10371976
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of IFN-gamma and IFN-alpha on killing of human trophoblast by decidual LAK cells.
    King A; Loke YW
    J Reprod Immunol; 1993 Jan; 23(1):51-62. PubMed ID: 8429524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen processing and presentation by human trophoblast-derived cell lines.
    Gobin SJ; Wilson L; Keijsers V; Van den Elsen PJ
    J Immunol; 1997 Apr; 158(8):3587-92. PubMed ID: 9103419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-G expression protects porcine endothelial cells from xenogeneic cytotoxicity mediated by human natural killer cells.
    Sasaki H; Xu XC; Smith D; Shenoy S; Lowell J; Howard T; Mohanakumar T
    Transplant Proc; 1999; 31(1-2):953-4. PubMed ID: 10083422
    [No Abstract]   [Full Text] [Related]  

  • 12. Endoplasmic reticulum aminopeptidase-1 mediates leukemia inhibitory factor-induced cell surface human leukocyte antigen-G expression in JEG-3 choriocarcinoma cells.
    Shido F; Ito T; Nomura S; Yamamoto E; Sumigama S; Ino K; Itakura A; Hattori A; Tsujimoto M; Mizutani S; Kikkawa F
    Endocrinology; 2006 Apr; 147(4):1780-8. PubMed ID: 16439450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity.
    Sasaki H; Xu XC; Smith DM; Howard T; Mohanakumar T
    Transplantation; 1999 Jan; 67(1):31-7. PubMed ID: 9921792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine stimulation of the choriocarcinoma cell line JEG-3 leads to alterations in the HLA-G expression profile.
    Persson G; Bork JBS; Isgaard C; Larsen TG; Bordoy AM; Bengtsson MS; Hviid TVF
    Cell Immunol; 2020 Jun; 352():104110. PubMed ID: 32387976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
    Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
    Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy.
    Barakonyi A; Kovacs KT; Miko E; Szereday L; Varga P; Szekeres-Bartho J
    J Immunol; 2002 Mar; 168(6):2683-8. PubMed ID: 11884433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine NK and LAK susceptibility is independent of class I expression on B lymphoblastoid variants.
    Li W; Splitter GA
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):189-200. PubMed ID: 7941303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
    Zidi I; Guillard C; Marcou C; Krawice-Radanne I; Sangrouber D; Rouas-Freiss N; Carosella ED; Moreau P
    Cell Mol Life Sci; 2006 Nov; 63(22):2669-81. PubMed ID: 17072500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
    Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
    Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The choriocarcinoma cell line JEG-3 upregulates regulatory T cell phenotypes and modulates pro-inflammatory cytokines through HLA-G.
    Melsted WN; Matzen SH; Andersen MH; Hviid TVF
    Cell Immunol; 2018 Feb; 324():14-23. PubMed ID: 29198970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.